focus -WSS

focus

author：knowledge 2025-09-27 17:02:55 - browse：5685

A doctor climbs up a red ladder to a vine shaped like a DNA — biotech coverage from STAT — Adobe

Every morning, Victoria Rasberry gets up before 6 a.m., walks to the bedroom down the hall, and helps her 8-year-old daughter Addi slide into a set of contraptions that squeeze and suck out the thick mucus constantly threatening to choke her airways closed. She feeds Addi breakfast through a stomach tube and makes sure she has the right mix of the 28 different medications required to keep her free of pain, infections, and seizures. At some point, Rasberry’s five other children will wake up and start to get ready for school, including her youngest, Oliver. At 3-and-a-half years old, he’s a typical toddler — always running and giggling and getting into things. You would never know that he and Addi were born with the same mutation lurking in their DNA, a genetic glitch that causes a fatal neurodegenerative disease called metachromatic leukodystrophy, or MLD.

“When Addi was this age she had lost the ability to speak and was already using a ventilator to sleep at night,” Rasberry said. “It’s amazing to see how well Ollie is doing in comparison. And it’s all because of the gene therapy.”

Three years ago, when Ollie was just 6 months old, he and Victoria traveled from their home in Texas to Milan, to receive a gene therapy treatment that adds a healthy version of the defective gene into patients’ own stem cells. At the time, traveling abroad for the therapy, which is manufactured by Orchard Therapeutics and was approved in Europe in 2021, was the only option for families stricken by MLD. But soon it will be available in the U.S., too.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Hundreds died while taking an arthritis drug, but nobody alerted patients

WSS

Overprescribed: High cost isn't America's only drug problem

What the cancer research community can learn from the Covid response

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

Oral obesity drug from Viking Therapeutics hits key early target

Covid silver lining: Unprecedented look at human immune system

Attacks on the drug industry will lead to fewer breakthroughs

leisure time

focus

focus

ChatGPT in medicine: STAT answers readers' burning questions

Trial using CRISPR to edit HIV out of cells disappoints

Walensky prepares to leave CDC — and Congress — behind

Stem cell clinics for heart failure: buyer be wary

Wildfire smoke exposes gaps in outdoor worker protections

Multiple sclerosis has subtypes with different best treatments: study

Trump demands the U.S. pay no more for drugs than other countries … again

Bird flu in dairy cattle: New measures to control spread to humans

How one medical school became remarkably diverse

Bird flu reported in person exposed to presumably infected cattle

focus

Insurer loopholes limit power of law against surprise medical bills

Humana, CVS hope to turn members into patients at clinics

Researchers test human milk's ability to repair gut microbiome

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

ER docs worry over extreme heat as a 'mass casualty event'

Dramatically reducing cancer deaths requires the PASTEUR Act

knowledge

explore

focus

explore